Your browser is no longer supported. Please, upgrade your browser.
BHC Bausch Health Companies Inc. monthly Stock Chart
BHC [NYSE]
Bausch Health Companies Inc.
Index- P/E- EPS (ttm)-5.45 Insider Own2.30% Shs Outstand355.60M Perf Week-0.51%
Market Cap6.91B Forward P/E4.45 EPS next Y4.39 Insider Trans-0.07% Shs Float347.91M Perf Month16.53%
Income-1923.00M PEG- EPS next Q1.06 Inst Own66.80% Short Float4.80% Perf Quarter15.49%
Sales8.04B P/S0.86 EPS this Y57.00% Inst Trans19.78% Short Ratio4.00 Perf Half Y1.93%
Book/sh1.65 P/B11.84 EPS next Y18.38% ROA-6.00% Target Price26.78 Perf Year-30.67%
Cash/sh2.76 P/C7.08 EPS next 5Y3.40% ROE-270.60% 52W Range11.15 - 31.97 Perf YTD-34.73%
Dividend- P/FCF10.62 EPS past 5Y-31.70% ROI-0.70% 52W High-38.91% Beta1.47
Dividend %- Quick Ratio0.90 Sales past 5Y0.90% Gross Margin72.10% 52W Low75.16% ATR0.69
Employees21700 Current Ratio1.20 Sales Q/Q-3.20% Oper. Margin-5.60% RSI (14)60.99 Volatility2.46% 3.73%
OptionableYes Debt/Eq41.47 EPS Q/Q242.70% Profit Margin-23.90% Rel Volume0.25 Prev Close19.17
ShortableYes LT Debt/Eq41.47 EarningsNov 03 BMO Payout- Avg Volume4.17M Price19.53
Recom2.20 SMA205.72% SMA5012.35% SMA2008.99% Volume1,033,040 Change1.88%
Sep-17-20Upgrade BofA Securities Underperform → Neutral $19
Aug-24-20Reiterated H.C. Wainwright Buy $64 → $50
Aug-24-20Reiterated H.C. Wainwright Buy $50 → $64
Jun-17-20Reiterated H.C. Wainwright Buy $50 → $64
Apr-24-20Initiated Citigroup Buy $30
Apr-02-20Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20Upgrade Wells Fargo Underweight → Equal Weight $32
Dec-12-19Upgrade JP Morgan Neutral → Overweight $32 → $38
Dec-02-19Initiated Goldman Neutral
Oct-25-19Initiated Cowen Outperform $35
Sep-12-19Initiated Guggenheim Buy
Aug-15-19Upgrade TD Securities Hold → Buy
Jul-19-19Initiated Wolfe Research Outperform
Jun-11-19Resumed Barclays Overweight $28
May-13-19Upgrade JP Morgan Underweight → Neutral
Mar-20-19Initiated SunTrust Buy $30
Jan-02-19Upgrade Piper Jaffray Neutral → Overweight
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-18Upgrade Piper Jaffray Underweight → Neutral
Nov-26-20 05:59AM  
Nov-25-20 10:36AM  
Nov-24-20 07:00AM  
Nov-18-20 04:51PM  
04:51PM  
07:08AM  
06:00AM  
Nov-17-20 10:09AM  
07:00AM  
Nov-16-20 07:00AM  
07:00AM  
Nov-12-20 07:05AM  
06:59AM  
06:59AM  
Nov-11-20 07:00AM  
Nov-10-20 10:25AM  
07:00AM  
07:00AM  
06:55AM  
Nov-05-20 08:00AM  
Nov-04-20 10:07AM  
06:06AM  
Nov-03-20 01:31PM  
08:25AM  
07:16AM  
06:59AM  
Nov-02-20 10:08AM  
08:30AM  
Nov-01-20 08:00AM  
Oct-29-20 04:05PM  
04:05PM  
07:00AM  
Oct-27-20 12:23PM  
11:52AM  
06:58AM  
Oct-26-20 06:58AM  
06:58AM  
Oct-22-20 07:00AM  
Oct-20-20 06:55AM  
06:26AM  
Oct-16-20 04:09AM  
Oct-15-20 07:00AM  
07:00AM  
Oct-13-20 03:40PM  
07:00AM  
Oct-12-20 07:00AM  
Oct-09-20 07:00AM  
Oct-08-20 01:39PM  
08:00AM  
08:00AM  
07:09AM  
07:00AM  
07:00AM  
Oct-06-20 07:00AM  
07:00AM  
Oct-05-20 07:00AM  
07:00AM  
Oct-01-20 07:00AM  
Sep-29-20 09:00AM  
Sep-28-20 10:19AM  
04:56AM  
Sep-25-20 11:24AM  
08:00AM  
Sep-24-20 07:00AM  
06:55AM  
06:55AM  
Sep-23-20 07:05AM  
07:00AM  
Sep-22-20 07:59AM  
07:00AM  
07:00AM  
Sep-21-20 07:00AM  
Sep-17-20 07:19PM  
Sep-16-20 10:26AM  
Sep-13-20 09:49AM  
Sep-10-20 12:00PM  
07:00AM  
07:00AM  
Sep-09-20 12:29PM  
07:00AM  
Sep-05-20 11:31AM  
Sep-03-20 07:05AM  
Sep-01-20 06:05PM  
Aug-31-20 07:08AM  
07:00AM  
07:00AM  
Aug-28-20 01:42PM  
Aug-25-20 01:30PM  
Aug-24-20 07:14PM  
11:20AM  
Aug-18-20 07:00AM  
Aug-17-20 07:00AM  
Aug-11-20 07:00AM  
Aug-07-20 01:35PM  
10:48AM  
Aug-06-20 11:03AM  
10:33AM  
09:59AM  
09:57AM  
09:55AM  
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Humphries William D.President, Ortho-DermatologicsSep 08Sale16.175,66791,635235,035Sep 10 04:34 PM
ValueAct Holdings, L.P.DirectorJun 05Buy19.24948,35318,246,31217,931,594Jun 09 08:24 PM
ValueAct Holdings, L.P.DirectorJun 05Sale19.24948,35318,246,3120Jun 09 08:24 PM
Paulson JohnDirectorMay 14Buy15.871,628,92025,857,83725,839,035May 14 06:25 PM
Paulson JohnDirectorMay 13Buy16.521,330,04421,972,61724,210,115May 14 06:25 PM
Paulson JohnDirectorMay 12Buy17.352,041,03635,421,08222,880,071May 14 06:25 PM
Ross Thomas W. Sr.DirectorMar 12Buy15.542,50038,83879,242Mar 16 04:24 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 10Buy18.254,39080,10691,635Mar 11 08:52 PM
VON ESCHENBACH ANDREW C.DirectorMar 10Buy18.181,10019,99618,565Mar 11 08:50 PM
DE SCHUTTER RICHARD UDirectorMar 10Buy18.263,80069,37713,800Mar 11 08:47 PM
DE SCHUTTER RICHARD UDirectorMar 03Buy23.085,000115,415279,250Mar 11 08:47 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.